<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Declarations</title>
 <notes id="FPar2" notes-type="COI-statement">
  <title>Conflict of interest</title>
  <p id="Par53">John G. Rizk, Carl J. Lavie, Youssef Rizk, and Donald N. Forthal report they have no conflicts of interest to disclose relative to this research. Kamyar Kalantar-Zadeh has received honoraria and/or support from Abbott, Abbvie, ACI Clinical (Cara Therapeutics), Akebia, Alexion, Amgen, Ardelyx, American Society of Nephrology (ASN), Astra-Zeneca, Aveo, BBraun, Chugai, Cytokinetics, Daiichi, DaVita, Fresenius, Genentech, Haymarket Media, Hofstra Medical School, International Federation of Kidney Foundations (IFKF), International Society of Hemodialysis (ISH), International Society of Renal Nutrition and Metabolism (ISRNM), Japanese Society of Dialysis Therapy (JSDT), Hospira, Kabi, Keryx, Kissei, Novartis, OPKO, National Institutes of Health (NIH), National Kidney Foundation (NKF), Pfizer, Regulus, Relypsa, Resverlogix, Dr Schaer, Sandoz, Sanofi, Shire, Veteransâ€™ Affairs (VA), Vifor, UpToDate, and ZS-Pharma. Mandeep R. Mehra reports consulting relationships with Abbott, Medtronic, Janssen, Mesoblast, Portola, Bayer, NupulseCV, FineHeart, Leviticus, Roivant, Baim Institute for Clinical Research, and Intrexon (Triple Gene).</p>
 </notes>
 <notes id="FPar3" notes-type="funding">
  <title>Funding</title>
  <p id="Par54">The authors received no financial support for the research, authorship, and/or publication of this article.</p>
 </notes>
</notes>
